Astellas Pharma
Manufacturing · Japan · 15,455 Employees
Who is Astellas Pharma
Astellas Pharma is engaged in the manufacturing, marketing, import, and export of pharmaceuticals. It is headquartered in Tokyo, Japan.Read More
Headquarters:
2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo, Tokyo, Japan
Phone Number:
+81 3-3244-3000
Revenue:
$11 Billion
Stock Symbol:
4503
Astellas Pharma's Social Media
Popular Searches:
Astellas Pharma Inc.
Astellas Pharma Inc
Astellas Pharma US , Inc.
Astellas
Astellas Pharma , Inc.
Top Competitors of Astellas Pharma
Astellas Pharma's Org Chart
Phone
EmailAstellas Pharma Email Formats
Astellas Pharma uses at least 5 email formats with first.last (ex. John.Smith@astellas.com) being used 68.6% of the time
Get Verified Emails
| Astellas Pharma Email Formats | Percentage | |
|---|---|---|
| first.last | John.Smith@astellas.com | 68.6% |
| first.last | John.Smith@us.astellas.com | 15.1% |
| first + last | JohnSmith@astellas.com | |
| first_last | John_Smith@astellas.com | |
| first | John@astellas.com | |
Astellas Pharma Company Metrics
Revenue
| Quarter | Revenue |
|---|---|
'21 - Q1 | 11546806000 |
'21 - Q2 | 11796370000 |
Acquisitions & Subsidiaries
Dec 08, 2018
Iota Biosciences
Jun 12, 2018
Ogeda
Jul 11, 2014
VESIcare
Dec 07, 2013
Euroscreen
Cadus
Cell Pathways
See More Acquisitions & Subsidiaries
Astellas Pharma's Tech Stack
Astellas Pharma News & Media
Astellas Submits Fezolinetant New Drug Application to U.S. FDA
Application targets treatment of moderate to severe vasomotor symptoms associated (VMS) with menopause TOKYO, June 23, 2022 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced a New Drug Application (NDA) for fezolinetant...
Jun 23, 2022
Astellas Celebrates the Opening of Its New Large-Scale Gene Therapy Manufacturing Facility in North Carolina
- 135,000 square-foot state-of-the-art gene therapy manufacturing facility located in Sanford, N.C., officially opened June 8 - Facility to support clinical- and commercial-scale manufacturing of Astellas' adeno-associated virus (AAV) vectors for gene therapies - Astellas' $100 million...Jun 8, 2022
Interstitial Cystitis Drugs Market - 36% of Growth to Originate from North America| Evolving Opportunities with Astellas Pharma Inc. & Bayer AG | 17000+ Technavio Reports
NEW YORK, June 1, 2022 /PRNewswire/ -- The "Interstitial Cystitis Drugs Market by Type (Oral therapy and Intravesical therapy) and Geography (North America, Europe, Asia, and ROW) - Forecast and Analysis 2021-2025" report has been added to Technavio's offering. With ISO 9001:2015...Jun 1, 2022Subscribe to "Astellas Pharma" News
Frequently Asked Questions regarding Astellas Pharma
Where are Astellas Pharma’s headquarters?
Astellas Pharma’s headquarters are in 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo, Tokyo, Japan
What is Astellas Pharma’s phone number?
Astellas Pharma’s phone number is +81 3-3244-3000
What is Astellas Pharma’s stock symbol?
Astellas Pharma’s stock symbol is 4503
What is Astellas Pharma’s official website?
Astellas Pharma’s official website is www.astellas.com
What is Astellas Pharma’s Revenue?
Astellas Pharma’s revenue is $11 Billion
What is Astellas Pharma’s SIC code?
Astellas Pharma’s SIC: 28,283
What is Astellas Pharma’s NAICS code?
Astellas Pharma’s NAICS: 62151,42421
How many employees are working in Astellas Pharma?
Astellas Pharma has 15,455 employees
What is Astellas Pharma’s industry?
Astellas Pharma is in the industry of: Manufacturing, Pharmaceuticals, Drug Stores & Pharmacies
Who are Astellas Pharma’s main competitors?
Astellas Pharma's main competitors are: LEO Pharma, Shionogi & Co, Takeda, Amneal
What companies has Astellas Pharma acquired?
Astellas Pharma has acquired the companies: Iota Biosciences, Ogeda, VESIcare, Euroscreen
What is Astellas Pharma's tech stack?
The technologies that are used by Astellas Pharma are: Microsoft Exchange Server 2010, SAP Warehouse Management, Apollo, Microsoft SQL Server Reporting
Who is Astellas Pharma's CEO?
Astellas Pharma's CEO is Kenji Yasukawa
Who is Astellas Pharma's CFO?
Astellas Pharma's CFO is Naoki Okamura
Rate Kenji Yasukawa as a President & Chief Executive Officer
User Ratings 
4.4/5 on G2 Crowd
Test Drive ZoomInfo's Directories
Browse Directories
